The pharmaceutical company raised its sales and operating profit guidance for 2014, as it posted a smaller than expected rise in fourth quarter net profit.
from WSJ.com: US Business http://ift.tt/1fhZULp
via IFTTT
from WSJ.com: US Business http://ift.tt/1fhZULp
via IFTTT
No comments:
Post a Comment